Author： Holst Jens Juul Burcelin Remy Nathanson Esther
Publisher： Informa Healthcare
ISSN： 1473-4877
Source： Current Medical Research and Opinion, Vol.27, Iss.3, 2011-03, pp. : 547-558
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The GLP‐1 system as a therapeutic target
By Edwards Mark
Annals of Medicine, Vol. 37, Iss. 5, 2005-09 ,pp. :
Access to resources
Recommend
WHODAS II – Practical and theoretical issues
By Wallesch Claus W. Schlote Andrea
Disability and Rehabilitation, Vol. 32, Iss. 8, 2010-01 ,pp. :
Liraglutide: a human GLP-1 analog for Type 2 diabetes
Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. :
GLP‐1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
OBESITY, Vol. 23, Iss. 6, 2015-06 ,pp. :